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The Mediterranean-style diet (MedDiet) involves substantial intake of fruits, vegetables, 
and fish, and a lower consumption of dairy, red meat, and sugars. Over the past 15 years, 
much empirical evidence supports the suggestion that a MedDiet may be beneficial 
with respect to reducing the incidence of cardiovascular disease, cancer, metabolic 
syndrome, and dementia. A number of cross-sectional studies that have examined the 
impact of MedDiet on cognition have yielded largely positive results. The objective of 
this review is to evaluate longitudinal and prospective trials to gain an understanding 
of how a MedDiet may impact cognitive processes over time. The included studies 
were aimed at improving cognition or minimizing of cognitive decline. Studies reviewed 
included assessments of dietary status using either a food frequency questionnaire or a 
food diary assessment. Eighteen articles meeting our inclusion criteria were subjected 
to systematic review. These revealed that higher adherence to a MedDiet is associated 
with slower rates of cognitive decline, reduced conversion to Alzheimer’s disease, and 
improvements in cognitive function. The specific cognitive domains that were found to 
benefit with improved Mediterranean Diet Score were memory (delayed recognition, 
long-term, and working memory), executive function, and visual constructs. The current 
review has also considered a number of methodological issues in making recommenda-
tions for future research. The utilization of a dietary pattern, such as the MedDiet, will be 
essential as part of the armamentarium to maintain quality of life and reduce the potential 
social and economic burden of dementia.
Keywords: nutrition, cognition, Mediterranean diet, clinical trials
NeUROCOGNiTive AGiNG AND THe POTeNTiAL 
ASSOCiATeD RiSK FACTORS
An aging population raises the potential for increased incidence of cognitive impairment (1). 
Preservation of brain function and the reduction of risk of neurological disorders have become 
key issues for society. In addition to the need to find treatments for disorders, such as Alzheimer’s 
disease (AD), it is becoming increasingly apparent that early intervention is critical for the 
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maintenance of brain health across the life span and reducing the 
risk of accelerated neurocognitive decline (2). There is mount-
ing evidence that risk factors for cardiovascular disease, stroke, 
diabetes, and other later-life chronic health conditions also 
exacerbate age-associated cognitive decline, which can lead to 
AD (3). Research is increasingly focusing on understanding how 
interventions, such as improving nutritional status and modify-
ing risk factors that may impinge directly and/or indirectly on 
brain functioning, can reduce the risk of neurocognitive impair-
ment (4). Closer adherence to a traditional Mediterranean-style 
diet (MedDiet) may be beneficial and protective with respect 
to addressing such risk factors, ultimately reducing the rate of 
cognitive decline (5).
Neurocognitive decline across the life span is well docu-
mented. In particular, cognitive faculties that involve speed of 
processing and memory steadily decline from the third decade 
of life (6). For example, the speed of retrieval of previously 
learned spatial locations from short-term memory is reduced 
by around 50% from the third to the eighth decade of life 
(7). While this slowing of memory retrieval is observed in all 
individuals, there is considerable intersubject variability in 
cognitive trajectories across the life span, particularly in later 
life (8). Individuals who are still cognitively intact, but who have 
shown accelerated cognitive decline, are potentially at risk of 
dementia and AD (9). It has been suggested that our individual 
cognitive trajectories relate to our overall health, and, as such, 
are potentially modifiable (10).
Aging affects multiple biological systems and organs, includ-
ing the brain (11). Much research has focused on the investigation 
of gross neuroanatomical changes with age. In recent years, this 
area has advanced through the adoption of high-resolution volu-
metric techniques, such as magnetic resonance imaging (MRI). 
Such methods reveal brain volume reduction at a rate of 5% per 
decade after the age of 40 years, with the rate of reduction possibly 
increasing after the age of 70 years (12). Other areas of investi-
gation include structural and functional changes at the cellular 
level. Neurocognitive aging is related to a lifelong incidence of 
molecular damage, with progressive destruction of both biomo-
lecular and cellular components (6). There are also neurochemi-
cal changes. For example, levels of brain-derived neurotrophic 
factor (BDNF) are known to reduce, which can impact synaptic 
plasticity and neurogenesis in the aging adult brain (13). Amyloid 
plaques and neurofibrillary tangles, the hallmarks of AD, have 
been extensively researched and occur commonly with age in 
cognitively intact individuals (12). Given the relevance of these 
neuropathological changes to AD, the origin of these changes and 
the potential risk for accelerated neurocognitive decline is being 
widely researched (14, 15).
The cardiovascular system offers prime examples of the rela-
tionship between lifestyle, health, and aging. As we age, our arter-
ies stiffen, and there is increased risk of cardiovascular disease, 
which has been associated with poor diet and lack of exercise 
(16). Stiffening of the arteries and increased blood pressure also 
increases the risk of stroke and neurodegeneration. Elevated 
systolic blood pressure has been shown to increase gray matter 
volume loss, which may eventually result in cognitive dysfunction 
(17). In addition to the consideration of increasing cardiovascular 
risks, it is important to also consider the important relation-
ship between blood pressure, high cholesterol, and obesity (3). 
These three factors are associated with what is referred to as the 
metabolic syndrome, a cluster of conditions typically including 
increased blood pressure and elevated blood sugar levels that can 
be associated with excess body fat around the waist and abnormal 
cholesterol levels. When combined, these conditions may increase 
the risk of heart disease, stroke, and diabetes (18).
Investigation of physiological changes at the molecular level 
has helped to elucidate possible mechanisms of action for the 
aforementioned changes in neural and cardiovascular func-
tioning. Inflammatory processes often increase with age and 
contribute to chronic disorders, such as arthritis, diabetes, and 
cardiovascular disease, as well as to neurodegenerative disorders, 
such as AD (19). It has also been proposed that age is associated 
with increased oxidative stress and free radical damage (20). 
Inflammation and oxidative stress may therefore be critical tar-
gets for the amelioration of declining health and brain function 
across the life span, which can potentially be addressed through 
improved nutrition and increased physical activity (21). However, 
as discussed below, there are very few controlled clinical trials 
that have utilized these simple interventions to investigate their 
effects on cognition in older individuals.
NUTRiTiON AND COGNiTive STATUS
The variability between individuals’ cognitive abilities in later life 
has been well documented (11, 12, 22, 23). The source of this vari-
ability has been related to both non-modifiable factors, such as 
age, gender, and genetics, as well as modifiable risk factors, such 
as stress, education, psychological well-being, and exercise (24).
Another particularly important modifiable risk factor for 
cognitive decline is dietary status. There is a wealth of literature, 
from both animal studies and human health research, indicating 
that diet can exert profound effects on biological aging (25–35). 
Diet can also affect other risk factors, such as inflammation and 
oxidation. Diets that are low in energy and that act to reduce 
oxidative stress may be protective against cognitive decline (25, 
36). Conversely, a diet that is high in energy and acts to increase 
oxidative stress may be considered a risk factor for impaired 
cognitive functioning (37).
Additionally, there are neurotrophic and neuroendocrine 
factors that may play a role in the cognitive responses that relate 
to food intake (38). Increasing consumption of fish and seafood 
by as little as one portion per month may be protective against 
stroke (39). Along with a healthy diet, there is evidence that low 
or moderate intake of alcohol may reduce cardiovascular and 
neurocognitive risk, with heavy drinkers tending to suffer more 
coronary infarcts and dementia (40, 41).
The dietary B-complex vitamins, which include B1 (thiamine), 
B2 (riboflavin), B3 (niacin), B5 (pantothenate), B6 (biotin, folate), 
and B12 (cobalamin), are important regulators of neurotrans-
mitter function (42). Vitamin B6, in particular, is an important 
cofactor for the enzymes that synthesize the neurotransmitters 
serotonin, epinephrine, and norepinephrine, and gamma-
aminobutyric acid (43). B vitamins may therefore affect central 
metabolism, brain function, and the modulation of mood, given 
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their role in neurotransmitter production (44–47). A lack of basic 
B vitamins (folic acid, B6, and B12) in the diet is also proposed to 
impact on the rate of brain atrophy associated with mild cognitive 
impairment (MCI) and with healthy aging (15).
It has also been proposed that a high intake of seafood and other 
sources of long-chain omega-3 polyunsaturated fats (LC-n3-FA) 
may have long-term beneficial effects on cognitive function (43, 
48, 49). For example, energy balance and LC-n3-FA act via BDNF, 
and insulin-like growth factor-1 (IGF-1) can alter the expression 
of a number of protein pathways that are involved in neuronal 
function, plasticity, and neurogenesis (50). The addition of regu-
lar fish consumption in one’s diet has also been shown to maintain 
gray matter volumes in the hippocampus, precuneus, posterior 
cingulate, and orbital cortex (51). As shown in Figure 1, these are 
examples of the many factors that can potentially modulate the 
action of nutrition on brain function.
THe MeDiTeRRANeAN DieT
The MedDiet was initially investigated in studies that described 
the food consumption in countries in Southern Europe. In par-
ticular, the dietary intake of the Mediterranean countries of Italy, 
Yugoslavia, and Greece were investigated, as these populations 
demonstrated a higher than average life expectancy, lower rates 
of cardiovascular disease, cancer, and other chronic disorders 
(52–54). The key components of a MedDiet are abundant con-
sumption of plant foods, such as leafy greens, fresh fruit and 
vegetables, cereals, beans, seeds, nuts, and legumes. The MedDiet 
is also low in dairy, has minimal red meats, and uses olive oil as 
its major source of fat (14).
Leafy vegetables are an important source of folate and 
other B vitamins (55, 56). The MedDiet has been reported to 
be protective against diseases associated with chronic inflam-
mation, cancer, diabetes, obesity, pulmonary disease, cardio-
vascular disease, and cognitive disorders (57). A diet with the 
nutritional qualities of the MedDiet has been shown to reduce 
homocysteine levels, considered a risk factor for age-associated 
cognitive decline (58, 59). The MedDiet pattern is largely void 
of refined sugar, cholesterol, and trans fats, aspects of diet that 
are considered to be associated with poor cognitive outcomes in 
older age (60, 61); with saturated fats impacting negatively on 
learning and memory and the potential for increasing metabolic 
distress (62). The effects of poor diet may be overcome by chang-
ing nutritional consumption, suggesting that a diet high in fruit 
and vegetables may assist in improving brain functioning over 
time (4, 43, 63–66).
There have been a substantial number of population/
epidemiological studies that have investigated adherence to a 
MedDiet and health outcomes, such as the population of 22,043 
adults in Greece who completed extensive food frequency ques-
tionnaires (FFQs) (26). Although this study did not review the 
effect of the MedDiet on cognition, it did indicate that adherence 
resulted in reduced mortality after 44 months of follow-up (26). 
Adherence to the MedDiet was also found to reduce the risk 
of myocardial infarction (27). The Italian Longitudinal Study 
on Aging, which was designed to assess the prevalence and 
incidence of certain chronic conditions in an older population, 
had a sample size of 5,632 subjects aged 65–68 years and found 
that an intake of 46 g per day or more of monounsaturated fatty 
acids, primarily from olive oil, as a part of the basic MedDiet, 
appeared to be protective against age-related changes in cogni-
tive function (67). In the Chicago Health and Aging Project 
(CHAPS) longitudinal study that assessed the incidence of AD 
and the habitual diet of 6,158 participants, it was found that 
greater adherence to all three healthy dietary styles that were 
assessed, including the MedDiet, was associated with a reduced 
incidence of AD. In a cross-sectional analysis of an Australian 
study, it was found that MedDiet adherence was not related to 
cognitive function. However, the consumption of plant foods 
associated with the MedDiet had a positive relationship with 
improving physical function and general health, while being 
negatively associated with anxiety, depression, and perceived 
stress (68).
These studies have provided evidence that the MedDiet may 
be protective against cognitive decline. However, there are poten-
tial confounding issues associated with both cross-sectional and 
longitudinal population studies that may not take into account 
minor reactive and biological changes that cannot be identified 
by observation.
THe MeDiTeRRANeAN DieT AND 
COGNiTiON – eviDeNCe FROM 
LONGiTUDiNAL AND PROSPeCTive 
TRiALS?
Over the past 15 years, there has been substantial research into 
the impact of adherence to the MedDiet pattern with respect to 
overall cardiovascular health, cognitive health, and the potential 
to reduce the onset of dementia and AD. The understanding of 
what a MedDiet is and the potential biological markers and nutri-
tional requirements of this diet have also been investigated. It is 
also important to segment the studies with clinical interventions 
from those that are considered observational studies.
This review focuses on studies that evaluate longitudinal 
and prospective trials in accordance with the specified criteria. 
The review explores our understanding of how a MedDiet 
may impact cognitive processes to gain an understanding of 
the cognitive endpoints following adherence to a MedDiet. 
Moreover, this review examines the various methodologies by 
which the MedDiet has been assessed and the assessment tools 
used to evaluate cognitive outcomes as well as identifying the 
key cognitive domains that that have been shown to be altered 
by adherence to the MedDiet.
MeTHODS
Study Selection
The following key words were searched: cognition, cognitive meas-
ures, control group, non-interventional group, Mediterranean 
diet patterns, and Mediterranean diet. In addition to these key 
words, for inclusion, the following conditions had to be met: the 
study must be a randomized or non-randomized trial, longitudi-
nal, or a prospective cohort study.
FiGURe 1 | Proposed mechanisms that link nutrition to changes in brain function. Adapted from Dauncey (23), with permission to reprint from Cambridge 
Press and authority to alter.
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Articles were excluded if they were focused on dementia only, 
depression only, child or adolescent depression only, AD only, 
Parkinson’s disease only, stroke or cardiovascular disease only, 
diabetes only, or a review of published work.
A literature search was carried out with the focus on 
articles  published between the years from 2000 to 2015. The 
following search engines were used: Directory of Open Access 
Journals, EBSCO Host Academic Search Complete Gale 
Cengage Academic One File, Google Scholar, Health Reference 
Center Academic, Health Reference Center (Gale), Highway 
Free Press, Journals @ Ovid, Journal reports, Medline, PubMed, 
Science Direct Freedom Collection, Scopus, Springer Link, Web 
of Science, Wiley Online Library, and Taylor & Frances Journal 
Complete.
The data extraction was carried out by one researcher, who 
completed the assessment in cooperation with the other authors 
to ensure that the capture of the information was relevant and 
consistent with the selection and exclusion criteria.
FiGURe 2 | PRiSMA diagram of the study selection process.
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The data extracted from each article included (1) character-
istics of the trial participants (number of participants, gender, 
and age); (2) study title, with respect to relevance and terminol-
ogy used; (3) year of publication; (4) study design and country 
of origin; (5) sample size; (6) FFQ; (7) MedDiet assessment; (8) 
cognitive assessments used; (9) cognitive sub-measures; and (10) 
study outcomes.
A study was included in the review if it had a measure of a 
MedDiet, a Mediterranean Diet Score (MedDietS) based on a 
numeric point scale as a result of any form of food frequency 
assessment, or total food intake. In addition, studies were also 
included if they used a MedDiet intervention with other key 
dietary components.
ReSULTS
included Studies
Independent searches utilizing the selection criteria identified 
173 trials, and after adjustment for duplicates, 129 articles 
remained for assessment. Of these, 79 were discarded after 
reviewing the abstracts and article content as they did not meet 
the criteria. This left the full text of 50 articles for general review. 
After allowing for the inclusion criteria and more extensive 
examination, 18 studies met the inclusion criteria. The selection 
procedure and the total number of eligible trials reviewed are 
shown in Figure 2.
Table  1 shows the data extracted from each of the trials. 
In summary, the age range of the participants that were included 
in this selection varied considerably, with two studies including 
younger adults (19–40 years), three studies looking at middle age 
(45–65 years), nine in the range (65–75 years), and four in the 
range (75+ years).
These trials including a number of different study designs are 
presented in Table 1.
Nutritional intake Assessments
One of the key elements required to assess the adherence to 
the MedDiet is to gain an understanding of the volume of food 
TABLe 1 | Summary of the included studies.
Study 
no.
Study  
author
Study design 
(Country of 
origin)
Age 
(years)
N Food frequency 
assessment
MedDiet 
assessment
Cognitive assessment Cognitive sub-measures Outcome
1 Scarmeas 
et al. (69)
Prospective 
cohort (USA)
76+ 1,984 61-item FFQ. 
Willett et al. (70)
Scored as in 
Trichopoulou et al. 
(26)
Visual Retention Test, Weschler 
Adult Intelligence Scale (WAIS)
Storage and retention, disordered 
memory and learning, visual 
retention
Higher adherence to a MedDiet 
decreases risk of AD
2 Féart et al. 
(71)
Prospective 
cohort (France)
65+ 1,410 FFQ and 24-h 
dietary recall
Scored as in 
Trichopoulou et al. 
(26)
MMSE, Isaac Set Test, Benton 
Visual Retention Test, Free and 
Cued Selective Reminding Test
Orientation, registration, 
attention, calculation, recall and 
language, controlled attention 
memory, semi-verbal fluency, 
speed of verbal production
MedDiet slower MMSE 
cognitive decline and not risk 
for incident dementia
3 Scarmeas 
et al. (72)
Multiethnic 
community 
longitudinal study 
(USA)
76–78 1,393 FFQ. Willett (70) Scored as in 
Trichopoulou et al. 
(26)
Neuropsychological battery, 
Global Clinical Dementia Rating 
(CDR)
Long- and short-term memory, 
judgment, and problem-solving
Higher adherence to a MedDiet 
associated with reduced risk 
of MCI, reduced conversion of 
MCI to AD
4 Gu et al. (73) Prospective 
cohort (USA)
65+ 1,219 Semi-qualitative 
61-item FFQ. 
Willett (70)
Scored as 
in Scarmeas 
et al. (72) and 
Trichopoulou et al. 
(26)
15 neuropsychological tests Long- and short-term verbal 
memory, short-term non-
verbal memory, orientation, 
construction, abstract reasoning, 
language
Higher adherence to a MedDiet 
associated with reduced risk 
of AD
5 McMillan 
et al. (74)
Randomized 
single-blind 
parallel groups 
(Australia)
19–30 27 FD None, MedDiet 
intervention with 
93% adherence
COMPASS Attention, working memory, long-
term working memory, executive 
function, response time, word 
recognition
MedDiet increases vigor, 
alertness, contentment, 
changes in cognitive function
6 Tangney 
et al. (34)
Data analysis of 
the CHAP study
≥65 3,790 Harvard FFQ Scored as in 
Panagiotakos et al. 
(75)
MMSE, East Boston tests of 
immediate and delayed recall, 
symbols digit modalities test
Immediate and delayed recall, 
orientation, registration, attention, 
calculation, recall and language
MedDiet associated with 
reduced rate of cognitive 
decline with older ageLongitudinal 
study (USA)
7 Cherbuin and 
Anstey (35)
Longitudinal 
study (Australia)
60–64 1,528 CSIRO FFQ Scored as in 
Scarmeas (72) and 
Trichopoulou (26)
International consensus criteria, 
CDR
Perceptual memory, motor 
function, simple and complex 
reaction time
MedDiet not protective against 
cognitive decline
8 Vercambre 
et al. (76)
Prospective 
cohort (women 
only) (USA)
65+ 2,504 FFQ 116 food 
groups. Willet (70)
Scored as in 
Trichopoulou (26)
TICS, telephone adaptation 
of the MMSE, verbal memory 
with the TICS 10-word list, East 
Boston memory test (EBMT)
Immediate and delayed recall, 
orientation, registration, attention, 
calculation, recall, and language
No association between 
MedDiet and 5-year cognitive 
change
9 Kesse-Guyot 
et al. (62)
Prospective 
cohort (France)
65.4 ± 4.6 3,083 French food 
composition table, 
computerized 
questionnaire FFQ
Mediterranean 
Dietary Pattern 
Score. Rumawas 
et al. (77)
Rappel indices 48-item (cued 
recall), verbal fluency tests of 
lexical/semantic memory
Episodic memory, working 
memory, verbal fluency, 
phonometric fluency
MedDiet adherence was not 
associated with cognitive 
performance overall
10 Martinez-
Lapiscina 
et al. (78)
Multicenter 
randomized 
(Spain)
74.6 ± 5.7 522 Semi-quantitative 
FFQ. Fernández-
Ballarth et al. (79)
14-item 
questionnaire. 
Martínez-gonzález 
et al. (27)
MMSE and Clock-Drawing 
Test (CDT), CDT language and 
comprehension
Working memory, visual and 
spatial orientation, orientation, 
registration, attention, calculation, 
recall and language
Higher adherence to a MedDiet 
intervention improved cognition 
compared with a low-fat diet
11 Samieri et al. 
(80)
Prospective 
epidemiological 
(USA)
≥70 16,058 USDA FFQ Scored as in 
Trichopoulou (26)
TICS, immediate and delayed 
recall of the EBMT, delayed 
recall of the TICS 10-word list, 
category fluency, Digital Spin 
backward
Global cognitive scores, 
immediate and delayed recall, 
verbal memory, language
Long-term adherence to the 
MedDiet pattern is modestly 
associated with global cognitive 
function and verbal memory in 
later life, but not with a cognitive 
change after a 6-year period
(Continued)
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Study 
no.
Study  
author
Study design 
(Country of 
origin)
Age 
(years)
N Food frequency 
assessment
MedDiet 
assessment
Cognitive assessment Cognitive sub-measures Outcome
12 Samieri et al. 
(81)
Randomized 
double-blind 
(USA)
65+ 6,174 131-item semi-
quantitative FFQ. 
Rimm et al. (82)
Scored as in Fung 
et al. (83)
TICS, immediate and delayed 
recall of the EBMT, delayed 
recall of the TICS 10-word test, 
category fluency
Recall memory, working memory, 
immediate and delayed recall, 
language
MedDiet not associated with 
cognitive decline; though 
certain dietary components may 
be related and warrant further 
investigation
13 Titova et al. 
(84)
Prospective 
cohort (Sweden)
70 194 FFQ. Rimm (82) Scored as in 
Trichopoulou (26)
Swedish 7-min screen for 
cognitive decline and dementia, 
Benton temporal orientation, 
CDT, categorical verbal fluency
Recall memory, temporal 
orientation, attention, verbal 
fluency
Reduced intake of meat and 
meat products associated with 
greater brain volume and better 
cognitive performance
14 Tsivgoulis 
et al. (85)
Prospective 
cohort (USA)
45–90 17,478 Food intake via a 
1-week diary
Scored as in 
Scarmeas et al. 
(72) and Féart 
et al. (71)
6-item screen. Callahan et al. 
(86)
Delayed memory High adherence to a MedDiet 
associated with reduced rate of 
incident cognitive impairment
15 Ye et al. (87) Longitudinal 
cohort (Puerto 
Rican adults in 
USA)
45–75 1,269 NHNS FFQ Scored as in 
Trichopoulou (26)
MMSE, word learning list 
forward and back, digit spin 
Stroop test, verbal fluency
Memory, attention, orientation, 
registration, calculation, 
recall and language learning, 
immediate recall, recognition and 
percent recognition
High adherence to a MedDiet 
associated with greater 
cognitive function and reduced 
risk of cognitive impairment
16 Galbete et al. 
(88)
Prospective 
cohort (Spain)
62 ± 6 824 Validated semi-
quantitative 
FFQ, MyPyramis 
Equivalent 
Database 2.0 for 
USDA Survey 
Foods 2003–2004. 
Bowman et al. (89)
Scored as in 
Trichopoulou (26)
Spanish TICS Immediate memory, delayed 
recall, orientation, attention, 
calculation, language
Higher adherence to a MedDiet 
associated with better cognitive 
outcomes
17 Lee et al. (90) Randomized 
trial – balanced 
crossover groups 
(Australia)
20–38 24 FD None, ≥80% 
adherence for 
dietary intervention
COMPASS Attention, working memory, long-
term memory, executive function
A MedDiet potential to 
enhance mood, cognition, and 
cardiovascular health in young 
adults
18 Valls-Pedret 
et al. (91)
Randomized 
trial – parallel 
groups (Spain)
67 (mean) 447 MedDiet program None/high 
compliance
MMSE, Rey Auditory Verbal 
Learning Test, Animals Semantic 
Fluency, Digit Span from the 
WAIS, Verbal Paired Association
Memory, attention, executive 
function
A MedDiet is associated with 
improved cognitive function
AD, Alzheimer’s disease; FD, food diary; FFQ, Food Frequency Questionnaire; CDR, global clinical dementia rating; CDT, clock-drawing test; CHAP, Chicago Health and Aging Project; COMPASS, computerized mental performance 
assessment system; CSIRO, Commonwealth Scientific and Industrial Research Organisation; EBMT, East Boston memory test; MedDiet, Mediterranean diet; MCI, mild cognitive impairment; MMSE, mini–mental state examination; 
TICS, telephone interview for cognitive status; USA, United States of America; USDA, United States Department of Agriculture; WAIS, Wechsler Adult Intelligence Scale.
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intake and the particular food groups used for assessment. The 
common approach to achieve this outcome is to have partici-
pants complete a food diary (FD) or an assessment of their food 
consumption through the use of a FFQ at time points as part 
of the trial protocol. In all of the original research studies that 
met the selection criteria for this analysis, the participants had 
completed either an FFQ or an FD. Of the 18 studies identified, 
14 utilized an FFQ, 3 utilized an FD, and 1 had a food program. 
The total number of categories of foods varied from a limited 
20 groups through to 250 different food groups, with data being 
collected over a range of time frames.
Mediterranean Diet Scores
The assessment of the MedDietS has been discussed in the 
literature since 2003. This initial research identified 150 food 
groups and placed these into 14 inclusive food groups (26). 
A sex-specific median calculation was used to determine the 
baseline value to assess the MedDietS with the 14 inclusive food 
groups, or nutrients were considered, where some groups were 
combined to eventually calculate a score ranging from 0 to 9. 
The sex-specific median allows for a comparative cut off to be 
made between genders on food consumption (26). Beneficial 
foods, such as vegetables, legumes, fruits, nuts, cereals, and fish, 
were assigned a value of 0, if a person’s consumption was below 
the median, and a score of 1, if it was above the median. With 
food components considered to be detrimental to health, such 
as meat, poultry, and dairy, consumption above the median 
was scored as 0, and intake below the median was scored as 1. 
For alcohol, a score of 1 was given, provided consumption was 
within a specified range. When considering fat intake, the ratio 
of monounsaturated lipids to polyunsaturated lipids was evalu-
ated with a higher ratio being more acceptable and a score of 
allocated accordingly.
Of the research included in this review, 10 papers referenced 
the Trichopoulou et  al. (26) study to calculate a MedDietS, 
while 5 created a MedDietS utilizing a mean score. There are 
three papers that did not produce a MedDietS. When making 
an assessment of the MedDietS, 6 studies used mean scores, 11 
used median scores, and 1 used a regression residual method. 
Three studies used a direct or total food amount. Although many 
studies utilized the original method to analyze the data, only four 
followed the sex-specific median approach. These were Articles 
1, 3, 4, and 9 in Table 1.
Cognitive Assessments
Generally, cognitive assessments utilize the mini–mental state 
examination (MMSE) (92). Of the 18 original research papers 
shown in Table  1, 6 utilized this tool in combination with 
other tests. Another seven studies used cognitive assessments 
administered as part of neuropsychological test batteries and 
other scales. These included the East Boston tests of immediate 
and delayed recall, the clinical dementia rating scale, 6-item 
screeners, telephone interviews, category fluency, Stroop tests, 
clock-drawing, and others. All of which were used as paper-based 
assessments. Two studies used a computer-based assessment for 
cognition  –  the computerized mental performance assessment 
(COMPASS) (74, 90). The cognitive domains that were assessed 
included measures of attention, working memory, long-term 
memory, and executive function.
Cognitive Results
Due to the heterogeneity of the selected studies that included a 
variety of experimental designs, cohorts, sampling times, as well 
as very diverse dietary and cognitive measures, it was not possible 
to pool data sets (102, 103). Instead, we used the dietary assess-
ment approach as a framework to report the cognitive outcomes 
from each study and discuss consistencies/inconsistencies more 
qualitatively.
Of the research that completed their assessment using a mean 
score to determine their MedDietS (Studies 6, 10, and 11), two 
found that higher adherence to the MedDiet resulted in slow rate 
of cognitive decline or improvements in cognition, including 
memory and immediate and delayed recall.
For those studies that used a median score for their MedDietS 
(Studies 2, 7, 8, 12, 13, 14, and 16), three showed that adherence 
to the MedDiet improved cognitive scores utilizing assessments 
of recognition memory, delayed recognition memory, or that this 
diet reduced the rate of cognitive decline utilizing assessments 
of working memory. In one study (Study 12), no relationship 
was found between the MedDiet intervention and cognitive 
decline; however, the authors did suggest that a specific food 
category, whole grains, merits further investigation with regard 
to cognition (81).
Four of the studies (Studies 1, 3, 4, and 9) also used a median 
score (sex-derived) to calculate the MedDietS. These studies 
analyzed the median score separately for men and women, as was 
done in the original study by Trichopoulou et al. (26). In three 
of these studies (Studies 1, 3, and 4), it was demonstrated that 
a higher adherence to a MedDiet was associated with a trend to 
reducing the risk of developing MCI (72), as measured using a 
global assessment and memory cognitive domains.
One study that did not use a mean or median calculation used 
a regression residual analysis method (Study 15). In this study, it 
was concluded that greater adherence to a MedDiet was associ-
ated with better cognitive function and a strong correlation with 
improvement in cognitive reserves when using MMSE, relating 
these outcomes to the cognitive domains of memory and atten-
tion (87).
In three studies, the absolute amount of food consumed in 
each category was used to assess adherence to a MedDiet. All 
reported high adherence to a MedDiet (Studies 5, 17, and 18). 
These studies demonstrated that a MedDiet supplemented with 
olive oil or nuts was associated with improved cognitive function 
and also that the MedDiet had the potential to enhance aspects 
of mood and cardiovascular function (74, 90, 91).
Finally, these trials were conducted in countries around 
the world with positive outcomes demonstrated both within 
and outside the Mediterranean region. There were six studies 
reporting positive cognitive outcomes in the USA, one study 
in France, three in Spain, one study in Sweden, and two in 
Australia.
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DiSCUSSiON
This review has explored the contention that the MedDiet has 
a long-term positive effect on cognitive function. The results 
of the dietary pattern, cognitive decline, and dementia reviews 
also support the proposition that adherence to a MedDiet pat-
tern is associated with less cognitive decline, dementia, or AD 
[69]. The primary aim of this review was to determine if adher-
ence to a MedDiet produces favorable outcomes in relation to 
improved cognition or minimization of cognitive decline. Of 
the 18 research articles examined, 13 demonstrated that higher 
adherence to a MedDiet was related to either slowing the rate of 
cognitive decline, minimizing the conversion to AD or improving 
the cognitive function. Five of the 18 studies did not demonstrate 
that MedDiet adherence had a protective effect against cogni-
tive decline or did not improve cognition. Irrespective of the 
study design, the studies that demonstrated improved cognitive 
outcomes examined the broad cognitive domains of attention, 
memory, and language. The studies that focused on the cognitive 
domains of motor or action did not report favorable outcomes 
when related to MedDiet adherence. The more specific cognitive 
domains that improved with MedDietS were memory, delayed 
recognition, executive function, long-term working memory, and 
visual constructs. These are mainly tests of fluid intelligence that 
decline with age (7). Interestingly, benefits to cognition afforded 
by the MedDiet were not exclusively in older individuals. The two 
studies included that were in younger adults both found improve-
ments in cognition using computerized assessments.
It is noted that although there are several different designs 
within the studies examined, including randomized or non-
randomized, that were longitudinal or prospective, and that may 
or may not have been interventional, it was difficult to assess if 
one or more particular designs reported more favorable outcomes 
with respect to adherence to a MedDiet and cognitive outcomes. 
It was also difficult to assess whether or not the calculation of 
the MedDietS, based on the original analysis of Trichopoulou 
et  al. (26), yielded more favorable cognitive outcomes. More 
specific approaches utilizing a median, mean, or sex-derived 
determination of MedDietS were similarly difficult to conclude 
if one approach was better than the other with respect to cogni-
tive outcomes, given the small number of studies and the mixed 
approaches for assessing cognition.
Six studies used the MMSE to examine a global measure of 
cognition. This measure was used mainly in trials examining 
cognitive decline and conversion to AD over a longer period of 
time. This seems reasonable given that the MMSE is a course tool 
for measuring cognition and is recommended mainly to identify 
accelerated aging and neurocognitive disorders, such as MCI and 
AD (93). Of the trials that used the MMSE to assess cognitive 
decline, three of the six trials showed either reduced cognitive 
decline or reduced conversion to MCI or AD. MMSE was also 
used to assess cognitive improvement  –  three out of six trials 
showed improvement in relation to adherence to a MedDietS. 
A higher rate of positive cognitive outcomes may have been 
realized if a more sensitive cognitive assessment tool was used. 
The studies that used the MMSE as their primary source of 
cognitive assessment measured cognitive decline as compared 
with the computer-based assessments that focused on cognitive 
improvement. The majority of the studies that used the MMSE 
also included cognitive assessments that measured memory, 
attention, language, and mood, such as the COMPASS, delayed 
recall from the Boston memory tests, the telephone interview of 
cognitive status (TICS) 10-word list, Stroop tests, verbal fluency 
measures, lexical semantic memory assessments, and clock-
drawing tests. Only two of the trials used a computer-based 
assessment for cognition, the COMPASS, both showing evidence 
of improved cognitive functioning in a short-term study with 
a 10-day intervention. The non-computer-based neuropsycho-
logical assessments in general showed improved cognition or a 
reduced cognitive decline in relation to a MedDietS. There were 
10 studies using these other neuropsychological assessments with 
6 showing cognitive change with regard to a MedDietS.
The studies examined used a range of methods to derive a 
MedDietS. Some studies used an FD, while others used various 
FFQ assessments. An FFQ is a way to estimate the food consumed 
over an extended period 6–12 months. An FD is a more specific and 
detailed assessment conducted over a number of days to quantify 
what one actually eats. There is no standardized pattern or agreed 
types of foods included in these forms of dietary assessments. The 
foods consumed can be considered specific to a region or country 
of origin, and the foods vary between studies, as they have been 
conducted in different countries and geographic areas. Generally, 
the food intake is recorded as it is relevant to the specific cohort 
under investigation. The FFQ has been found to be reproducible 
and have good comparative validity. The FFQ has demonstrated 
dietary intervention effects to be relatively accurate (94–96). 
When converted to different languages, the validity of the FFQ 
was also reproducible, such as with the Brazilian, Chinese, and 
Italian populations (97–100).
Across the 18 studies, there was no standardization of the most 
appropriate FFQ. There was a large variation in the FFQs adopted, 
and the selection of food groups ranged from 70 to 250 different 
groups. It is also important to consider portion sizes, as some 
studies used food frequency alone. It is more appropriate for 
comparison to include portion size by food groups with respect to 
gender and ethnicity (101). Portion size needs to be determined 
based on the norms for the country under investigation and 
reported in grams per day for equivalence. The adherence to a 
standardized pattern of a MedDiet as demonstrated in the initial 
research conducted in 2003, Trichopoulou et al. (26) also needs to 
be assessed. This original research, which forms the focus of many 
of the studies conducted to date, used 14 all-inclusive food groups 
that were evaluated in grams per day, and consequently prospec-
tive studies need to adhere to this specific pattern of evaluation to 
ensure valid comparisons can be made.
To ensure that direct correlations can be made between stud-
ies, it would be of value to have a standardized computer-based 
FFQ that is easy to administer and simple to review. The use of 
a standardized FFQ that utilizes 14 all-inclusive food groups all 
evaluated to grams per day, and this would enable more accurate 
portions of food taken (grams per day) to be evaluated to obtain 
a MedDietS.
Interestingly, positive cognitive effects were found in countries 
around the world, including those outside of the Mediterranean 
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region. Many of these positive studies used an approach where a 
mean or median is determined for each food category, and adher-
ence for the individual is scored relative to this mean or median. 
In this way, habitual dietary habits are normalized with respect to 
the local region. Change over time is assessed relative to baseline 
scores to assess whether or not greater adherence supports better 
cognitive health. While this makes it difficult to compare absolute 
measures of dietary adherence in relation to a more traditional 
Mediterranean diet (26), it is encouraging that measurable shifts 
in adherence within a local population are effective in improving 
cognition or retarding cognitive decline. An important challenge 
will be to demonstrate a sustainable long-term shift in diet within 
a population that also confers cognitive benefits.
CONCLUSiON AND FUTURe DiReCTiONS
This review has analyzed longitudinal and prospective trials in 
accordance with the specified criteria to gain an understanding 
of how a MedDiet may impact cognitive processes. The level 
of adherence to the MedDiet has subsequently been evaluated 
against various cognitive domains to ascertain the potential 
protective nature of this diet pattern with respect to minimizing 
cognitive decline, improving cognitive decline, or reducing the 
incidence of conversion of MCI to AD.
The overall outcome from this review indicates that there is 
encouraging evidence that a higher adherence to a MedDiet is 
associated with improving cognition, slowing cognitive decline, 
or reducing the conversion to AD.
With few studies available to assess benefits of a MedDiet 
intervention in a healthy older population, it is recommended 
that further randomized controlled trials need to be conducted. 
These trials need to include a standard food consumption 
assessment that can be validated to determine the impact of 
cognitive changes over time. It is also recommended that future 
RCTs utilize validated computer-based cognitive batteries that 
are sensitive to cognitive faculties, which are compromised 
with age and potentially amenable to interventions, such as a 
MedDiet. Future studies should also consider the use of blood, 
cardio, and fecal biomarkers that will allow for mechanisms 
of action to be evaluated. Biomarkers will provide more 
direct measures of dietary status and will potentially elucidate 
important biological changes that relate to brain function and 
modifiable risk factors.
Further focused research in this area is important due to the 
expected extensive population aging over the next 20–30 years. 
The utilization of such a dietary pattern will be essential as part 
of the armamentarium to maintain quality of life and reduce the 
potential social and economic burden of dementia.
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